Part of a series on the |
COVID-19 pandemic |
---|
|
COVID-19 portal |
The Mu variant, also known as lineage B.1.621 or VUI-21JUL-1, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. It was first detected in Colombia in January 2021 and was designated by the WHO as a variant of interest on August 30, 2021. [1] On 16 March 2022, the WHO has de-escalated the Mu variant and its subvariants to "previously circulating variants of concern". [2] [3]
The WHO said the variant has mutations that indicate a risk of resistance to the current vaccines and stressed that further studies were needed to better understand it. [4] [5] Outbreaks of the Mu variant were reported in South America and Europe. [6] The B.1.621 lineage has a sublineage, labeled B.1.621.1 under the PANGO nomenclature, which has already been detected in more than 20 countries worldwide. [7]
Under the simplified naming scheme proposed by the World Health Organization, B.1.621 was labeled "Mu variant", and was considered a variant of interest (VOI), but not a variant of concern. [1]
In January 2021, the lineage was first documented in Colombia and was named as lineage B.1.621. [8]
On July 1, 2021, Public Health England (PHE) named lineage B.1.621 VUI-21JUL-1. [9]
On August 30, 2021, the World Health Organization (WHO) named lineage B.1.621 Mu variant. [1]
The Mu genome has a total number of 21 mutations, including 9 amino acid mutations, all of which are in the virus's spike protein code: T95I, Y144S, Y145N, R346K, E484K or the escape mutation, N501Y, D614G, P681H, and D950N. [10] It has an insertion of one amino acid at position 144/145 of the spike protein, giving a total mutation YY144–145TSN. That mutation is conventionally notated as Y144S and Y145N because insertions would break a lot of comparison tools. It also features a frame-shift deletion of four nucleotides in ORF3a that generates a stop codon two amino acids. The mutation is labeled as V256I, N257Q, and P258*. The list of defining mutations are: S: T95I, Y144S, Y145N, R346K, E484K, N501Y, D614G, P681H, and D950N; ORF1a: T1055A, T1538I, T3255I, Q3729R; ORF1b: P314L, P1342S; N: T205I, ORF3a: Q57H, V256I, N257Q, P258*; ORF8: T11K, P38S, S67F. [11] Mutations in viruses are not new. All viruses, including SARS-CoV-2, undergo change over time. Most of these changes are inconsequential, but some can alter properties to make these viruses more virulent or escape the treatment or vaccines. [6]
On August 31, 2021, the WHO released an update which stated that the "Mu variant has a constellation of mutations that indicate potential properties of immune escape", noting that preliminary studies showed some signs of this but that "this needs to be confirmed by further studies." [12]
One such study conducted in a lab in Rome tested the effectiveness of sera collected from recipients of the BioNTech-Pfizer vaccine against the Mu variant, and found that "neutralization of SARS-CoV-2 B.1.621 lineage was robust", albeit at a lower level than that observed against the B.1 variant. [13]
Gene | Amino acid |
---|---|
ORF1a | T1055A |
T1538I | |
T3255I | |
Q3729R | |
ORF1b | P314L |
P1342S | |
S | T95I |
Y144S | |
Y145N | |
R346K | |
E484K | |
N501Y | |
D614G | |
P681H | |
D950N | |
ORF3a | Q57H |
del257/257 | |
ORF8 | T11K |
P38S | |
S67F | |
N | T205I |
August 6:
August 30:
September 2:
September 3:
September 4:
September 7:
September 8:
September 9:
September 16:
September 18:
Country | GISAID [38] | outbreak.info [10] | other sources |
---|---|---|---|
USA | 5,550 | 6,550 | |
Colombia | 3,995 | 4,974 | |
Chile | 850 | 958 | |
Spain | 665 | 690 | |
Ecuador | 352 | 447 | |
Mexico | 345 | 435 | |
Peru | 240 | 276 | 86 [24] |
Canada | 142 | 162 | |
Dominican Republic | 115 | 118 | |
Aruba | 94 | 94 | |
Italy | 82 | 85 | |
Netherlands | 76 | 76 | 46 [39] |
Costa Rica | 73 | 74 | |
United Kingdom | 71 | 67 | 59 [40] |
Puerto Rico | 57 | 57 | |
Belgium | 51 | 51 | |
Austria | 49 | 49 | |
Switzerland | 48 | 48 | |
Argentina | 41 | 42 | 1 [32] |
British Virgin Islands | 41 | 41 | |
Jamaica | 33 | 33 | 26 [29] |
France | 29 | 28 | |
Mongolia | 20 | 20 | |
Portugal | 20 | 25 | |
Curacao | 19 | 20 | |
Brazil | 17 | 21 | 12 [33] [34] [35] [36] |
Panama | 16 | 16 | |
Germany | 15 | 16 | |
Venezuela | 15 | 15 | |
Denmark | 11 | 12 | |
Bolivia | 10 | 10 | |
Bonaire | 8 | 10 | |
Poland | 8 | 8 | |
Finland | 5 | 5 | 1 [37] |
Haiti | 5 | 6 | |
Japan | 5 | 5 | 2 [16] |
U.S. Virgin Islands | 5 | 5 | 1 [26] |
Ireland | 4 | 4 | 4 [23] |
Slovakia | 4 | 4 | |
Sweden | 4 | 4 | |
Guatemala | 3 | 4 | 2 [18] |
Hong Kong | 3 | 3 | 3 [21] |
Luxembourg | 3 | 3 | |
Cayman Islands | 2 | 3 | |
Israel | 2 | 2 | |
Saint Vincent and the Grenadines | 2 | 3 | 5 [28] |
Sint Maarten | 2 | 3 | |
Turkey | 2 | 2 | 2 [27] |
Barbados | 1 | 1 | |
Czech Republic | 1 | 1 | |
Gibraltar | 1 | 1 | |
Liechtenstein | 1 | 1 | |
Lithuania | 1 | 1 | |
Malta | 1 | 1 | |
Morocco | 1 | 1 | |
South Korea | 1 | 1 | 3 [22] |
Turks and Caicos Islands | 1 | 1 | |
Romania | 1 | 1 | |
Greece | 1 | 1 | 6 [20] |
Taiwan | 1 | 1 | 1 [17] |
Total | 12,952 | 15,090 | 260 |
The COVID-19 pandemic was confirmed to have reached South America on 26 February 2020 when Brazil confirmed a case in São Paulo. By 3 April, all countries and territories in South America had recorded at least one case.
Cluster 5 is a designation used by the Danish Statens Serum Institut for a virus variant described by the institute in autumn 2020, in connection with investigations of SARS-CoV-2 infection among mink and humans in the north of Jutland, Denmark.
The Alpha variant (B.1.1.7) was a SARS-CoV-2 variant of concern. It was estimated to be 40–80% more transmissible than the wild-type SARS-CoV-2. Scientists more widely took note of this variant in early December 2020, when a phylogenetic tree showing viral sequences from Kent, United Kingdom looked unusual.
The Beta variant, (B.1.351), was a variant of SARS-CoV-2, the virus that causes COVID-19. One of several SARS-CoV-2 variants initially believed to be of particular importance, it was first detected in the Nelson Mandela Bay metropolitan area of the Eastern Cape province of South Africa in October 2020, which was reported by the country's health department on 18 December 2020. Phylogeographic analysis suggests this variant emerged in the Nelson Mandela Bay area in July or August 2020.
Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are viruses that, while similar to the original, have genetic changes that are of enough significance to lead virologists to label them separately. SARS-CoV-2 is the virus that causes coronavirus disease 2019 (COVID-19). Some have been stated, to be of particular importance due to their potential for increased transmissibility, increased virulence, or reduced effectiveness of vaccines against them. These variants contribute to the continuation of the COVID-19 pandemic.
The Gamma variant (P.1) was one of the variants of SARS-CoV-2, the virus that causes COVID-19. This variant of SARS-CoV-2 has been named lineage P.1 and has 17 amino acid substitutions, ten of which in its spike protein, including these three designated to be of particular concern: N501Y, E484K and K417T. It was first detected by the National Institute of Infectious Diseases (NIID) of Japan, on 6 January 2021 in four people who had arrived in Tokyo having visited Amazonas, Brazil, four days earlier. It was subsequently declared to be in circulation in Brazil. Under the simplified naming scheme proposed by the World Health Organization, P.1 was labeled Gamma variant, and was considered a variant of concern until March 2022, when it was largely displaced by the delta and omicron variants.
The following is a timeline of the COVID-19 pandemic in the United States during 2021.
Iota variant, also known as lineage B.1.526, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. It was first detected in New York City in November 2020. The variant has appeared with two notable mutations: the E484K spike mutation, which may help the virus evade antibodies, and the S477N mutation, which helps the virus bind more tightly to human cells.
The Delta variant (B.1.617.2) was a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in India on 5 October 2020. The Delta variant was named on 31 May 2021 and had spread to over 179 countries by 22 November 2021. The World Health Organization (WHO) indicated in June 2021 that the Delta variant was becoming the dominant strain globally.
Theta variant, also known as lineage P.3, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. The variant was first identified in the Philippines on February 18, 2021, when two mutations of concern were detected in Central Visayas. It was detected in Japan on March 12, 2021, when a traveler from the Philippines arrived at Narita International Airport in Tokyo.
Kappa variant is a variant of SARS-CoV-2, the virus that causes COVID-19. It is one of the three sublineages of Pango lineage B.1.617. The SARS-CoV-2 Kappa variant is also known as lineage B.1.617.1 and was first detected in India in December 2020. By the end of March 2021, the Kappa sub-variant accounted for more than half of the sequences being submitted from India. On 1 April 2021, it was designated a Variant Under Investigation (VUI-21APR-01) by Public Health England.
Lineage B.1.617 is a lineage of SARS-CoV-2, the virus that causes COVID-19. It first came to international attention in late March 2021 after the newly established INSACOG performed genome sequencing on positive samples throughout various Indian states. Analysis of samples from Maharashtra had revealed that compared to December 2020, there was an increase in the fraction of samples with the E484Q and L452R mutations. Lineage B.1.617 later came to be dubbed a double mutant by news media.
The Lambda variant, also known as lineage C.37, is a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in Peru in August 2020. On 14 June 2021, the World Health Organization (WHO) named it Lambda variant and designated it as a variant of interest. On 16 March 2022, the WHO has de-escalated the Lambda variant to "previously circulating variants of concern".
Epsilon variant, also known as CAL.20C and referring to two PANGO lineages B.1.427 and B.1.429, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. It was first detected in California, USA in July 2020.
Zeta variant, also known as lineage P.2, is a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in the state of Rio de Janeiro; it harbors the E484K mutation, but not the N501Y and K417T mutations. It evolved independently in Rio de Janeiro without being directly related to the Gamma variant from Manaus.
The Eta variant is a variant of SARS-CoV-2, the virus that causes COVID-19. The Eta variant or lineage B.1.525, also called VUI-21FEB-03 by Public Health England (PHE) and formerly known as UK1188, 21D or 20A/S:484K, does not carry the same N501Y mutation found in Alpha, Beta and Gamma, but carries the same E484K-mutation as found in the Gamma, Zeta, and Beta variants, and also carries the same ΔH69/ΔV70 deletion as found in Alpha, N439K variant and Y453F variant.
Omicron (B.1.1.529) is a variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance in South Africa on 24 November 2021. It was first detected in Botswana and has spread to become the predominant variant in circulation around the world. Following the original B.1.1.529 variant, several subvariants of Omicron have emerged including: BA.1, BA.2, BA.3, BA.4, and BA.5. Since October 2022, two subvariants of BA.5 called BQ.1 and BQ.1.1 have emerged.
This timeline of the SARS-CoV-2 Omicron variant is a dynamic list, and as such may never satisfy criteria of completeness. Some events may only be fully understood and/or discovered in retrospect.
BA.2.86 is an Omicron subvariant of SARS-CoV-2, the virus that causes COVID-19. BA.2.86 is notable for having more than thirty mutations on its spike protein relative to BA.2. The subvariant, which was first detected in a sample from 24 July 2023, is of concern due to it having made an evolutionary jump on par with the evolutionary jump that the original Omicron variant had made relative to Wuhan-Hu-1, the reference strain first sequenced in Wuhan in December 2019. It is a mutation of BA.2, itself a very early mutation in the Omicron family. BA.2.86 was designated as a variant under monitoring by the World Health Organization on 17 August 2023. The variant was nicknamed Pirola by T. Ryan Gregory, although no official sources use this name. Its descendant JN.1 (BA.2.86.1.1) became the dominating Lineage in Winter 2023/2024.